Johns Hopkins ABX Guide
Imiquimod
INDICATIONS
FDA
FDA
- Condyloma acuminatum
- Actinic keratoses in immunocompetent adults (typical, nonhyperkeratotic, nonhypertrophic)
- Primary superficial basal cell carcinoma in immunocompetent adults
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 9, 2022
Citation
Dzintars, Kathryn, et al. "Imiquimod." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540282/all/Imiquimod.
Dzintars K, Auwaerter PG, Hsu AJ. Imiquimod. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540282/all/Imiquimod. Accessed January 13, 2025.
Dzintars, K., Auwaerter, P. G., & Hsu, A. J. (2022). Imiquimod. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540282/all/Imiquimod
Dzintars K, Auwaerter PG, Hsu AJ. Imiquimod [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2025 January 13]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540282/all/Imiquimod.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Imiquimod
ID - 540282
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Auwaerter,Paul,M.D.
AU - Hsu,Alice,Pharm.D.
Y1 - 2022/11/09/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540282/all/Imiquimod
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
